Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatobiliary abnormalities in inflammatory bowel disease.

K J van Erpecum1, G P van Berge Henegouwen

  • 1Department of Gastroenterology and Hepatology, University Hospital Utrecht, The Netherlands.

The Netherlands Journal of Medicine
|June 1, 1989
PubMed
Summary

Inflammatory bowel disease (IBD) can cause liver and bile duct issues. Early detection of primary sclerosing cholangitis in IBD patients may offer a better prognosis, but intervention timing is debated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intra-gastric balloon with lifestyle modification: a promising therapeutic option for overweight and obese patients with metabolic dysfunction-associated steatotic liver disease.

Internal and emergency medicine·2023
Same author

Stauffer's syndrome: A true entity?

Clinics and research in hepatology and gastroenterology·2021
Same author

Retrieval of chronic hepatitis C patients. A manifesto for action to eliminate hepatitis C in the Netherlands: the CELINE project.

The Netherlands journal of medicine·2019
Same author

Strategies for achieving viral hepatitis C micro-elimination in the Netherlands.

Hepatology, medicine and policy·2018
Same author

Ribavirin steady-state plasma level is a predictor of sustained virological response in hepatitis C-infected patients treated with direct-acting antivirals.

Alimentary pharmacology & therapeutics·2017
Same author

How the concept of biochemical response influenced the management of primary biliary cholangitis over time.

The Netherlands journal of medicine·2016

Area of Science:

  • Gastroenterology
  • Hepatology
  • Internal Medicine

Background:

  • Hepatobiliary abnormalities are common in inflammatory bowel disease (IBD).
  • Conditions include hepatic amyloidosis, granulomas, fatty infiltration, and increased gallstone prevalence in Crohn's ileitis.
  • Primary sclerosing cholangitis (PSC) affects approximately 5% of IBD patients, potentially leading to serious complications.

Purpose of the Study:

  • To review the spectrum of hepatobiliary manifestations in IBD.
  • To discuss the diagnosis, prognosis, and management of primary sclerosing cholangitis in IBD patients.
  • To evaluate the optimal timing for diagnostic procedures like endoscopic cholangiography.

Main Methods:

  • Review of existing literature on IBD-associated hepatobiliary conditions.

Related Experiment Videos

  • Analysis of diagnostic modalities including liver biopsy and endoscopic cholangiography.
  • Discussion of current and emerging therapeutic strategies for PSC.

    • Main Results:

    • PSC is a significant complication in IBD, with potential for severe outcomes like cholangitis and bile duct cancer.
    • Increased awareness and diagnostic tools lead to earlier detection of PSC, even in asymptomatic patients.
    • Prognosis for detected PSC may be better than previously assumed, though this is debated.

    Conclusions:

    • Endoscopic cholangiography might be deferred until symptoms arise to mitigate procedure-related risks.
    • Liver biopsy offers prognostic insights, complementing cholangiography.
    • Emerging therapies for PSC show promise but require validation through controlled trials.